Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

samuraciclib (CT7001)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Carrick Therap

Drug class:

CDK7 inhibitor

Related drugs:

No biomarker	Triple Negative Breast Cancer	No biomarker	Triple Negative Breast Cancer	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	CT7001 Sensitive: C3 – Early Trials CT7001 Sensitive : C3	CT7001 Sensitive: C3 – Early Trials CT7001 Sensitive : C3